Brii Biosciences Limited (BRIBF)

USD 0.13

(0.0%)

Revenue Summary of Brii Biosciences Limited

  • Brii Biosciences Limited's latest annual revenue in 2023 was 617 Thousand CNY , down -98.8% from previous year.
  • Brii Biosciences Limited's latest quarterly revenue in 2024 Q2 was 1.52 Million USD , down 0.0% from previous quarter.
  • Brii Biosciences Limited reported a annual revenue of 51.62 Million CNY in annual revenue 2022, up 254.52% from previous year.
  • Brii Biosciences Limited reported a annual revenue of 14.56 Million CNY in annual revenue 2021, up 15.62% from previous year.
  • Brii Biosciences Limited reported a quarterly revenue of 1.53 Million USD for 2024 Q1, up 36.55% from previous quarter.
  • Brii Biosciences Limited reported a quarterly revenue of - USD for 2023 Q4, down -100.0% from previous quarter.

Annual Revenue Chart of Brii Biosciences Limited (2023 - 2019)

Historical Annual Revenue of Brii Biosciences Limited (2023 - 2019)

Year Revenue Revenue Growth
2023 617 Thousand CNY -98.8%
2022 51.62 Million CNY 254.52%
2021 14.56 Million CNY 15.62%
2020 12.59 Million CNY 334.24%
2019 2.9 Million CNY 0.0%

Peer Revenue Comparison of Brii Biosciences Limited

Name Revenue Revenue Difference
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 96.088%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -3401.504%
SQZ Biotechnologies Company 21.47 Million USD 97.127%
Evofem Biosciences, Inc. 18.21 Million USD 96.613%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.498%
Mesoblast Limited 5.9 Million USD 89.546%
Propanc Biopharma, Inc. - USD -Infinity%
Genus plc 668.8 Million USD 99.908%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -50.427%
Marizyme, Inc. 645.81 Thousand USD 4.461%
ContraFect Corporation - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -703.794%
Intellipharmaceutics International Inc. 65.72 Thousand USD -838.717%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -1461.314%
MultiCell Technologies, Inc. 49.32 USD -1250913.788%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 98.759%
EV Biologics, Inc. 48.9 Thousand USD -1161.759%
Q BioMed Inc. 284.35 Thousand USD -116.985%
Emmaus Life Sciences, Inc. 29.59 Million USD 97.915%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.748%
Oncotelic Therapeutics, Inc. 70 Thousand USD -781.429%
Skye Bioscience, Inc. - USD -Infinity%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -523.27%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -714.801%
IMV Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 6.302%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.996%
Halberd Corporation 999.00 USD -61661.762%
Enzolytics Inc. 52.79 Thousand USD -1068.649%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 54.931%
SYBLEU INC 11.69 Thousand USD -5175.308%
Nuo Therapeutics, Inc. 608.52 Thousand USD -1.393%
argenx SE 1.22 Billion USD 99.95%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 68.064%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 0.062%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.927%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.575%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD -10.631%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 38.159%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 98.724%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 16.68 Million USD 96.302%
ONE Bio Corp. 52.29 Million USD 98.82%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -160.822%
Regen BioPharma, Inc. 236.56 Thousand USD -160.822%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -339.954%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -30.243%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 92.079%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -4646.154%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -1460.682%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 81.471%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 90.743%
IntelGenx Technologies Corp. 1.03 Million USD 40.616%
Gelesis Holdings, Inc. 25.76 Million USD 97.605%
CSL Limited 14.8 Billion USD 99.996%
Cellectis S.A. 755 Thousand USD 18.278%